1. Sign our petition calling on Cochrane to withdraw their review of Exercise Therapy for 'CFS'.
    Dismiss Notice
  2. Guest, the 'News in Brief' for the week beginning 13th January 2025 is here.
    Dismiss Notice
  3. Welcome! Read the Core Purpose and Values of our forum.
    Dismiss Notice

rintatolimod

  1. Sly Saint
    Thread

    Ampligen in Phase 2 Clinical Study for the Treatment of Post-COVID Conditions

    Several posts have been moved from this thread: Ampligen - Hemispherx Biopharma re ME/CFS not relating to ME but Covid-19 AIM ImmunoTech inks...
    Thread by: Sly Saint, May 3, 2020, 35 replies, in forum: Long Covid research
  2. cassava7
    Thread

    A Double-Blind, Placebo-Controlled, Randomized, Clinical Trial of the TLR-3 Agonist Rintatolimod in Severe Cases of CFS, Strayer et al, 2012

    Background Chronic fatigue syndrome/myalgic encephalomyelitis (CFS/ME) is a severely debilitating disease of unknown pathogenesis consisting of a...
    Thread by: cassava7, Jul 28, 2022, 15 replies, in forum: ME/CFS research
  3. Andy
    Thread

    Effect of disease duration in a randomized Phase III trial of rintatolimod, an immune modulator for [ME/CFS], 2020, Mitchell et al

    Rintatolimod = Ampligen A hypothesis-based post-hoc analysis of the Intent to Treat (ITT) population diagnosed with ME/CFS from 12 independent...
    Thread by: Andy, Oct 30, 2020, 16 replies, in forum: ME/CFS research
  4. Andy
    Thread

    Leveraging Prior Knowledge of Endocrine Immune Regulation in the Therapeutically Relevant Phenotyping of Women With CFS, 2019, Morris et al

    Abstract PURPOSE: The complex and varied presentation of myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) has made it difficult to...
    Thread by: Andy, Apr 2, 2019, 9 replies, in forum: ME/CFS research
Showing results 1 to 4 of 4